Paras Biopharma (Biologics CDMO) Announces Industry Leading

Paras Biopharma (Biologics CDMO) Finland team is pleased to announce that its extensive efforts have resulted in the successful scale-up, optimization &...

Related Keywords

Finland , Cytofold Structquant , Mark Jackson , Paras Biopharma , Clinical Development , Biologics Biosimilar Technology Development , Analytical Method Development , Method Qualifications , Method Validations , European Biopharma , Immune Thrombocytopenia , Paras Product Pipeline , Immune Thrombocytopenic Purpura , Paras Biopharmaceutical , Biosimilar Technology Development ,